Transversus Abdominis Plane Block Versus Erector Spinae Plane Block
Study Details
Study Description
Brief Summary
The TAP block, first described by Rafi in 2001, is comprised of deposition of a local anesthetic into the anatomical plane between the internal oblique and transverses abdominis muscles, where thess thoracoabdominal nerves (T6-L1) contribute to the main sensory supply of the skin, muscles, and parietal peritoneum of the anterior abdominal wall. These nerves branch and communicate extensively with each other in the TAP .
Erector spinae plane (ESP) block is a recently described interfascial block in which the local anaesthectic is placed over or below the plane of the erector spinae muscle, near where the spinal nerves come out from the spine before they start to divide. Some publications have shown its effectiveness in treating thoracic and abdominal postoperative pain.
Postoperative pain is the major obstacle for early postoperative ambulation and increases the risk of venous thromboembolism, respiratory complications and prolongs the hospital stay. Parietal pain is the chief component of postoperative pain after abdominal surgeries. Large doses of opioids are required to mitigate this pain, but they are poorly tolerated. Multimodal analgesia is effective in handling postoperative pain and in attenuating the side effects of large doses of a single analgesic .
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Group I (A group): Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side).
Group II (B group): Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side).
Group III (C group): anesthetized with the protocol followed by Minia University Hospital The medication will be prepared and supplied in similar syringes by an anesthetist not included in the management of the patint or data collection.
Methods:
Following placement of the standard monitors, intravenous access will secured and the patients will started on IV fluids. Anesthesia will be induced with 0.04 mg/kg midazolam, 2 μg/kg fentanyl, and titrated doses of propofol. Endotracheal intubation will facilitated with 0.5 mg/kg of atracurium. Isoflurane 1.2%, will be used for anesthetic maintenance After induction of anesthesia, stabilizing the patient's hemodynamics, and before surgical incision, ESB & TAP block will be performed. With the patient in the supine position, the site of the ultrasound and needle entry will be sterilized. The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected. Then the patient will turn in lateral position, the site of the ultrasound and needle entry will be sterilized. The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Group I (A group) 31 patients Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side). |
Procedure: erector spinae plane block
The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes
|
Active Comparator: Group II (B group) 31patients Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side). |
Procedure: transversus abdominis plane block
The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected
|
Placebo Comparator: Group III (C group) 31 patients anesthetized with the protocol followed by Minia University Hospital |
Other: control group
placebo
|
Outcome Measures
Primary Outcome Measures
- Time of First Post Operative Analgesic Request [24 hours]
the pain will be assisted based on the time for the first dose of rescue analgesia
- Postoperative Total Fentanyl Requirement [24 hours]
The total amount of postoperative fentanyl in milligram was given to the patient as rescue analgesia during 24 hours
Secondary Outcome Measures
- Incidence of Any Adverse Events [5 days]
adverse events related to technique or drugs
Eligibility Criteria
Criteria
Inclusion Criteria:
-
- Age18-70 . 2. Both gender . 3 .Emergency laparotomies . 4. ASA I-III .
Exclusion Criteria:
-
Drug allergy .
-
Morbid obesity (BMI >40 kg/m2) .
-
Psychiatric disorder .
-
Opioid dependence .
-
patient refuse
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Minia University Hospital | Minya | Egypt | 61511 |
Sponsors and Collaborators
- Hassan Mokhtar Elshorbagy Hetta
Investigators
- Study Chair: Nagy S. Ali, MD, Minia University Hospital
- Study Director: Abeer A Hassanien, Minia University Hospital
Study Documents (Full-Text)
More Information
Publications
None provided.- 73-7/2018
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail | 7 patient refuse to participate |
Arm/Group Title | Group I (A Group) | Group II (B Group) | Group III (C Group) |
---|---|---|---|
Arm/Group Description | 31 patients Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side). erector spinae plane block: The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes | 31patients Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side). transversus abdominis plane block: The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected | 31 patients anesthetized with the protocol followed by Minia University Hospital control group: placebo |
Period Title: Overall Study | |||
STARTED | 31 | 31 | 31 |
COMPLETED | 31 | 31 | 31 |
NOT COMPLETED | 0 | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Group I (A Group) | Group II (B Group) | Group III (C Group) | Total |
---|---|---|---|---|
Arm/Group Description | 31 patients Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side). erector spinae plane block: The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes | 31patients Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side). transversus abdominis plane block: The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected | 31 patients anesthetized with the protocol followed by Minia University Hospital control group: placebo | Total of all reporting groups |
Overall Participants | 31 | 31 | 31 | 93 |
Age (years) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [years] |
45.8
(14.9)
|
47.4
(11.8)
|
43.6
(13.7)
|
45.61
(13.46)
|
Sex: Female, Male (Count of Participants) | ||||
Female |
15
48.4%
|
14
45.2%
|
16
51.6%
|
45
48.4%
|
Male |
16
51.6%
|
17
54.8%
|
15
48.4%
|
48
51.6%
|
Ethnicity (NIH/OMB) (Count of Participants) | ||||
Hispanic or Latino |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Not Hispanic or Latino |
31
100%
|
31
100%
|
31
100%
|
93
100%
|
Unknown or Not Reported |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Race (NIH/OMB) (Count of Participants) | ||||
American Indian or Alaska Native |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Asian |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Native Hawaiian or Other Pacific Islander |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Black or African American |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
White |
31
100%
|
31
100%
|
31
100%
|
93
100%
|
More than one race |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Unknown or Not Reported |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Region of Enrollment (participants) [Number] | ||||
Egypt |
31
100%
|
31
100%
|
31
100%
|
93
100%
|
Outcome Measures
Title | Time of First Post Operative Analgesic Request |
---|---|
Description | the pain will be assisted based on the time for the first dose of rescue analgesia |
Time Frame | 24 hours |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Group I (A Group) | Group II (B Group) | Group III (C Group) |
---|---|---|---|
Arm/Group Description | 31 patients Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side). erector spinae plane block: The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes | 31patients Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side). transversus abdominis plane block: The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected | 31 patients anesthetized with the protocol followed by Minia University Hospital control group: placebo |
Measure Participants | 31 | 31 | 31 |
Mean (Standard Deviation) [Hour] |
14.9
(5.7)
|
6.5
(2.2)
|
2.8
(1.6)
|
Title | Postoperative Total Fentanyl Requirement |
---|---|
Description | The total amount of postoperative fentanyl in milligram was given to the patient as rescue analgesia during 24 hours |
Time Frame | 24 hours |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Group I (A Group) | Group II (B Group) | Group III (C Group) |
---|---|---|---|
Arm/Group Description | 31 patients Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side). erector spinae plane block: The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes | 31patients Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side). transversus abdominis plane block: The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected | 31 patients anesthetized with the protocol followed by Minia University Hospital control group: placebo |
Measure Participants | 31 | 31 | 31 |
Mean (Standard Deviation) [Milligram] |
40.3
(26.7)
|
111
(38.1)
|
175
(38.9)
|
Title | Incidence of Any Adverse Events |
---|---|
Description | adverse events related to technique or drugs |
Time Frame | 5 days |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Group I (A Group) | Group II (B Group) | Group III (C Group) |
---|---|---|---|
Arm/Group Description | 31 patients Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side). erector spinae plane block: The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes | 31patients Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side). transversus abdominis plane block: The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected | 31 patients anesthetized with the protocol followed by Minia University Hospital control group: placebo |
Measure Participants | 31 | 31 | 31 |
Number [participants] |
0
0%
|
0
0%
|
0
0%
|
Adverse Events
Time Frame | 5 days | |||||
---|---|---|---|---|---|---|
Adverse Event Reporting Description | All patients were under control and receive the best care of management Our techniques don't make any side effects or affect patients outcome | |||||
Arm/Group Title | Group I (A Group) | Group II (B Group) | Group III (C Group) | |||
Arm/Group Description | 31 patients Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side). erector spinae plane block: The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes | 31patients Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side). transversus abdominis plane block: The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected | 31 patients anesthetized with the protocol followed by Minia University Hospital control group: placebo | |||
All Cause Mortality |
||||||
Group I (A Group) | Group II (B Group) | Group III (C Group) | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/31 (0%) | 0/31 (0%) | 0/31 (0%) | |||
Serious Adverse Events |
||||||
Group I (A Group) | Group II (B Group) | Group III (C Group) | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/31 (0%) | 0/31 (0%) | 0/31 (0%) | |||
Other (Not Including Serious) Adverse Events |
||||||
Group I (A Group) | Group II (B Group) | Group III (C Group) | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/31 (0%) | 0/31 (0%) | 0/31 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr. Hassan Elshorbagy |
---|---|
Organization | Minia university |
Phone | 1204427271 ext 0020 |
Hassan.Hetta@mu.edu.eg |
- 73-7/2018